Bold Therapeutics, Inc.
6Patents
6Active
6Granted
44Portfolio score
Filing activity: Mar 1, 2017 → Jul 20, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10611787B2 | Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof | Human Necessities | 3 | Active |
| US11040993B2 | Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof | Human Necessities | 2 | Active |
| US10821095B2 | Use of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] for the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US11739111B2 | Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof | Human Necessities | 1 | Active |
| US12415825B2 | Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof | Human Necessities | 0 | Active |
| US11633380B2 | Use of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.